Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.60% | 0.68% | 32.51% | 35.60% | -3.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.60% | 0.68% | 32.51% | 35.60% | -3.48% |
| Cost of Revenue | -9.86% | -11.55% | 29.10% | 32.12% | -23.80% |
| Gross Profit | 6.99% | 4.98% | 33.77% | 36.90% | 6.52% |
| SG&A Expenses | -1.35% | -3.20% | -43.40% | -42.08% | -35.73% |
| Depreciation & Amortization | -16.43% | -17.99% | 4.62% | 7.09% | 20.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.69% | -6.47% | -29.65% | -28.00% | -30.24% |
| Operating Income | 60.45% | 61.19% | 109.37% | 109.59% | 77.65% |
| Income Before Tax | 99.28% | 99.29% | 102.48% | 102.54% | -80.41% |
| Income Tax Expenses | -99.40% | -99.41% | 100.70% | 100.73% | 455.71% |
| Earnings from Continuing Operations | 99.32% | 99.33% | 102.78% | 102.84% | -258.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.32% | 99.33% | 102.78% | 102.84% | -258.55% |
| EBIT | 60.45% | 61.19% | 109.37% | 109.59% | 77.65% |
| EBITDA | 91.40% | 103.57% | 126.38% | 126.99% | 77.69% |
| EPS Basic | 99.48% | 99.48% | 102.18% | 102.17% | -258.44% |
| Normalized Basic EPS | 96.67% | 96.67% | 101.99% | 101.98% | 68.20% |
| EPS Diluted | 99.48% | 99.48% | 102.18% | 102.17% | -258.44% |
| Normalized Diluted EPS | 96.67% | 96.67% | 101.99% | 101.98% | 68.20% |
| Average Basic Shares Outstanding | 30.48% | 30.48% | 24.41% | 24.41% | 0.04% |
| Average Diluted Shares Outstanding | 30.48% | 30.48% | 30.44% | 30.44% | 0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |